|
ZNF788 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.043300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.588220E-02 |
| Normal-vs-Stage2 |
1.809600E-01 |
| Normal-vs-Stage3 |
1.226420E-04 |
| Normal-vs-Stage4 |
9.279300E-03 |
| Stage1-vs-Stage2 |
5.191400E-01 |
| Stage1-vs-Stage3 |
4.010000E-02 |
| Stage1-vs-Stage4 |
3.841000E-01 |
| Stage2-vs-Stage3 |
4.435600E-02 |
| Stage2-vs-Stage4 |
2.368800E-01 |
| Stage3-vs-Stage4 |
6.080400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.161300E-03 |
| Normal-vs-AfricanAmerican |
1.126420E-01 |
| Normal-vs-Asian |
2.559700E-02 |
| Caucasian-vs-AfricanAmerican |
7.416400E-01 |
| Caucasian-vs-Asian |
9.967000E-01 |
| AfricanAmerican-vs-Asian |
7.829600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.829600E-02 |
| Normal-vs-Female |
1.235170E-03 |
| Male-vs-Female |
1.576570E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.678000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.497500E-03 |
| Normal-vs-Age(61-80Yrs) |
6.300000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.133160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.305200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.161400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.752600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.567600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.344600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.954200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.100200E-02 |
| Classical-VS-Follicular |
6.973800E-01 |
| Classical-VS-Other |
2.490200E-01 |
| Classical-VS-Normal |
1.612480E-02 |
| Tall-VS-Follicular |
1.882420E-01 |
| Tall-VS-Other |
6.505800E-01 |
| Tall-VS-Normal |
2.584500E-03 |
| Follicular-VS-Other |
3.447800E-01 |
| Follicular-VS-Normal |
2.579900E-02 |
| Other-VS-Normal |
3.950000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.255600E-03 |
| Normal-vs-N1 |
3.64369999994452E-06 |
| N0-vs-N1 |
3.099600E-03 |
|
|
